RxSight, Inc. (RXST) stock
RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3076% below fair value
$5.01+0.18 (+3.73%)
Close on Nov 18, 2026Market cap $208.38MP/E –Yield –
RxSight pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
RxSight's pe ratio was 1.3× on Oct 29, 2021.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Oct 29, 2021 | 1.3× | – |
See a number that looks wrong?